The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.
Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
31 | 73 | 14 | 21 |
Growth
|
81 | 45 | 93 | 35 |
Safety
|
27 | 37 | 15 | 87 |
Sentiment
|
27 | 9 | 26 | 33 |
|
24 | 21 | 10 | 25 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Analyst Opinions
|
36 | 32 | 44 | 20 |
Opinions Change
|
72 | 15 | 57 | 50 |
Pro Holdings
|
n/a | 36 | 25 | 73 |
Market Pulse
|
20 | 14 | 52 | 46 |
Sentiment
|
27 | 9 | 26 | 33 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Value
|
31 | 73 | 14 | 21 |
Growth
|
81 | 45 | 93 | 35 |
|
27 | 37 | 15 | 87 |
Combined
|
35 | 53 | 21 | 30 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Price vs. Sales (P/S)
|
40 | 40 | 40 | 8 |
Price vs. Earnings (P/E)
|
72 | 68 | 5 | 13 |
Price vs. Book (P/B)
|
19 | 76 | 40 | 54 |
Dividend Yield
|
1 | 1 | 1 | 1 |
Value
|
31 | 73 | 14 | 21 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Revenue Growth
|
76 | 96 | 94 | 91 |
Profit Growth
|
62 | 6 | 60 | 1 |
Capital Growth
|
84 | 83 | 84 | 87 |
Stock Returns
|
51 | 13 | 69 | 13 |
Growth
|
81 | 45 | 93 | 35 |
Metrics | Current | 2024 | 2023 | 2022 |
---|---|---|---|---|
Leverage
|
10 | 13 | 8 | 100 |
Refinancing
|
93 | 92 | 57 | 89 |
Liquidity
|
13 | 17 | 28 | 4 |
|
27 | 37 | 15 | 87 |
Discover high‑ranked alternatives to Pacific Biosciences of California and broaden your portfolio horizons.
The Obermatt Advantage
Choose the Obermatt subscription that best fits your needs.